Cerebrospinal fluid substance P-like immunoreactivity correlates with aggression in personality disordered subjects

Biological Psychiatry

Volumn 72, Issue 3, 2012, Pages 238-243

  Coccaro, Emil F ^a   Lee, Royce ^a   Owens, Michael J ^b   Kinkead, Becky ^b   Nemeroff, Charles B ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Aggression; CSF; impulsivity; neurokinin 1; personality; substance P

Indexed keywords

SUBSTANCE P;

ADULT; AGGRESSION; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; IMMUNOREACTIVITY; IMPULSIVENESS; MALE; NERVE CELL MEMBRANE POTENTIAL; NEUROMODULATION; PERSONALITY DISORDER; PRIORITY JOURNAL;

ADULT; AGGRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HOSTILITY; HUMANS; IMPULSIVE BEHAVIOR; MALE; NEUROPSYCHOLOGICAL TESTS; PERSONALITY DISORDERS; PSYCHIATRIC STATUS RATING SCALES; RADIOIMMUNOASSAY; SPINAL PUNCTURE; SUBSTANCE P;

EID: 84863720466     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2012.02.023     Document Type: Article

References (59)

1. Harrison S, Geppetti P (2001): Substance P. Int J Biochem Cell Biol 33:555-576. (Pubitemid 32510811)
2. Atar P, Srivastava S, Coutinho E, Govil G (2004): Substance P: Structure, function, and therapeutics. Curr Top Med Chem 4:75-103. (Pubitemid 38849358)
3. von Euler US, Gaddum JH (1931): An unidentified depressor substance in certain tissue extracts. J Physiol 72:74-87.
4. Maggi CA (1995): The mammalian tachykinin receptors. Gen Pharmacol 26:911-944.
5. Yip J, Chahl LA (2001): Localization of NK1 and NK3 receptors in guineapig brain. Regul Pept 98:55-62. (Pubitemid 32155493)
6. Gobbi G, Cassano T, Radja F, Morgese MG, Cuomo V, Santarelli L, et al. (2007): Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function. Eur Neuropsychopharmacol 17:328-338.
7. Zubrzycka M, Janecka A (2000): Substance P: Transmitter of nociception (minireview). Endocr Regul 34:195-201. (Pubitemid 33712110)
8. Ebner K, Singewald N (2006): The role of substance P in stress and anxiety responses. Amino Acids 31:251-72. (Pubitemid 44537051)
9. Huston JP, Hasenöhrl RU, Boix F, Gerhardt P, Schwarting RK (1993): Sequence-specific effects of neurokinin substance P on memory, reinforcement, and brain dopamine activity. Psychopharmacology 112:147-162. (Pubitemid 23278274)
10. Park SW, Yan YP, Satriotomo I, Vemuganti R, Dempsey RJ (2007): Substance P is a promoter of adult neural progenitor cell proliferation under normal and ischemic conditions. J Neurosurg 107:593-599. (Pubitemid 47451044)
11. Smith GS, Savery D, Marden C, Lopez Costa JJ, Averill S, Priestley JV, et al. (1994): Distribution of messenger RNAs encoding enkephalin, substance P, somatostatin, galanin, vasoactive intestinal polypeptide, neuropeptide Y, and calcitonin gene-related peptide in the midbrain periaqueductal grey in the rat. J Comp Neurology 350:23-40. (Pubitemid 24351573)
12. Bhatt S, Gregg TR, SiegelA(2003): NK1 receptors in the medial hypothalamus potentiate defensive rage behavior elicited from the midbrain periaqueductal gray of the cat. Brain Res 966:54-64. (Pubitemid 36315840)
13. Gregg TR, Siegel A (2001): Brain structures and neurotransmitters regulating aggression in cats: Implications for human aggression. Prog Neuropsychopharmacol Biol Psychiatry 25:91-140. (Pubitemid 32173790)
14. Han Y, Shaikh MB, Siegel A (1996): Medial amygdaloid suppression of predatory attack behavior in the cat: I. Role of a substance P pathway from the medial amygdala to the medial hypothalamus. Brain Res 716:59-71. (Pubitemid 26156600)
15. Shaikh MB, Steinberg A, Siegel A (1993): Evidence that substace P is utilized in medial amygdaloid facilitation of defensive rage behavior in the cat. Brain Res 625:283-294. (Pubitemid 23300425)
16. Gregg TR, Siegel A (2003): Differential effects of NK1 receptors in the midbrain periaqueductal gray upon defensive rage and predatory attack in the cat. Brain Res 994:55-66. (Pubitemid 37452437)
17. Beyer C, Caba M, Banas C, Komisaruk BR (1991): Vasoactive intestinal polypeptide (VIP) potentiates the behavioral effect of substance P intrathecal administration. Pharmacol Biochem Behav 39:695-698.
18. Barbeau A, Rondeau DB, Jolicoeur FB (1980): Behavioral effects of substance P in rats. Int J Neurol 14:239-252.
19. Elliott PJ, Iversen SD (1986): Behavioural effects of tachykinins and related peptides. Brain Res 381:68-76. (Pubitemid 16049659)
20. American Psychiatric Association (1994): Diagnostic and Statistical Manual: Fourth Edition (DSM-IV). Washington, DC: American Psychiatric Press.
21. Coccaro EF (2011): Intermittent explosive disorder: Development of integrated research criteria for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Compr Psychiatry 52:119-125.
22. Bunce SC, Noblett KL, McCloskey MS, Coccaro EF (2005): High prevalence of personality disorders among healthy volunteers for research: Implications for control group bias. J Psychiatr Res 39:421-430. (Pubitemid 40404092)
23. Coccaro EF, Berman ME, Kavoussi RJ (1997): Assessment of life history of aggression: Development and psychometric characteristics. Psychiatry Res 73:147-157. (Pubitemid 28088171)
24. Buss AH, Durkee A (1957): An inventory for assessing different kinds of hostility. J Consult Psychol 21:343-348.
25. Eysenck SBG, Eysenck HJ (1977): The place of impulsiveness in a dimensional system of personality description. Br J Soc Clin Psychol 16:57-68. (Pubitemid 8042781)
26. Patton JH, Stanford MS, Barratt ES (1995): Factor structure of the Barratt impulsiveness scale. J Clin Psychol 51:768-774. (Pubitemid 26021724)
27. Coccaro EF, Lee R, Kavoussi, RJ (2010): Aggression, suicidality, and intermittent explosive disorder: Serotonergic correlates in personality disorder and healthy control subjects. Neuropsychopharmacology 35:435-444.
28. Eysenck HJ, Eysenck SBG (1975): Manual of the Eysenck Personality Questionnaire. London: Hodder and Stoughton.
29. Coccaro EF, Lee R (2010): Cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid: Reciprocal relationships with impulsive aggression in human subjects. J Neural Transm 117:241-248.
30. Anand P, Gibson SJ, McGregor GP, Blank MA, Ghatei MA, Bacarese-Hamilton AJ, et al. (1983): A VIP-containing system concentrated in the lumbosacral region of human spinal cord. Nature 305:143-145. (Pubitemid 14235669)
31. Fernandes ES, Schmidhuber SM, BrainSD(2009): Sensory-nerve-derived neuropeptides: Possible therapeutic targets. Handb Exp Pharmacol 194:393-416.
32. Nutt JG (1983): Substance P in human CSF. In: Wood JH, editor. Neurobiology of Cerebrospinal Fluid, Vol. 2. New York: Plenum Press, 95.
33. Landgraf R, Klauschenz E, Bienert M, Ermisch A, Oehme P (1983): Some observations indicating a low brain uptake of [3H]Nle11-Substance P. Pharmazie 38:108-110. (Pubitemid 13146856)
34. Rimón R, Le Grevés P, Nyberg F, Heikkilä L, Salmela L, Terenius L (1984): Elevation of substance P-like peptides in the CSF of psychiatric patients. Biol Psychiatry 19:509-516. (Pubitemid 14146477)
35. Geracioti TD Jr, Carpenter LL, Owens MJ, Baker DG, Ekhator NN, Horn PS, et al. (2006): Elevated cerebrospinal fluid substance P concentrations in posttraumatic stress disorder and major depression. Am J Psychiatry 163:637-643. (Pubitemid 44464573)
36. Li L, Gao X, Zhao J, Ji X, Wei H, Luo Y (2009): Plasma and cerebrospinal fluid substance P in post-stroke patients with depression. Psychiatry Clin Neurosci 63:298-304.
37. Carpenter LL, Bayat L, Moreno F, Kling MA, Price LH, Tyrka AR, et al. (2008): Decreased cerebrospinal fluid concentrations of substance P in treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy. Psychiatry Res 157:123-129. (Pubitemid 350167564)
38. Stockmeier CA, Shi X, Konick L, Overholser JC, Jurjus G, Meltzer HY, et al. (2002): Neurokinin-1 receptors are decreased in major depressive disorder. Neuroreport 13:1223-1227. (Pubitemid 34722058)
39. Burnet PW, Harrison PJ (2000): Substance P (NK1) receptors in the cingulate cortex in unipolar and bipolar mood disorder and schizophrenia. Biol Psychiatry 47:80-83. (Pubitemid 30016083)
40. Bondy B, Baghai TC, Minov C, Schüle C, Schwarz MJ, Zwanzger P, et al. (2003): Substance P serum levels are increased in major depression: preliminary results. Biol Psychiatry 53:538-542. (Pubitemid 36331893)
41. Deuschle M, Sander P, Herpfer I, Fiebich BL, Heuser I, Lieb K (2005): Substance P in serum and cerebrospinal fluid of depressed patients: No effect of antidepressant treatment. Psychiatry Res 136:1-6. (Pubitemid 41032967)
42. Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, et al. (1998): Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281:1640-1645. (Pubitemid 28435572)
43. Keller M, Montgomery S, Ball W, Morrison M, Snavely D, Liu G, et al. (2006): Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder. Biol Psychiatry 59:216-223. (Pubitemid 43208967)
44. Strittmatter M, Grauer M, Isenberg E, Hamann G, Fischer C, Hoffmann KH, et al. (1997): Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia. Headache 37:211-216. (Pubitemid 27215340)
45. Martinez M, Frank A, Hernanz A (1993): Relationship of interleukin-1 beta and beta 2-microglobulin with neuropeptides in cerebrospinal fluid of patients with dementia of the Alzheimer type. J Neuroimmunol 48:235-240.
46. De Felipe C, Herrero JF, O'Brien JA, Palmer JA, Doyle CA, Smith AJ, et al. (1998): Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 392:394-397. (Pubitemid 28168736)
47. Barbaresi P (1998): Immunocytochemical localization of substance P receptor in rat periaqueductal gray matter: A light and electron microscopic study. J Comp Neurol 398:473-490.
48. Gallagher AW, Chahl LA, Lynch AM (1992): Distribution of substance P-like immunoreactivity in guinea pig central nervous system. Brain Res Bull 29:199-207.
49. Rosen A, Brodin K, Eneroth P, Brodin E (1992): Short-term restraint stress and s.c. saline injection alter the tissue levels of substance P and cholecystokinin in the peri-aqueductal grey and limbic regions of rat brain. Acta Physiol Scand 146:341-348.
50. Moss MS, Basbaum AI (1983): The peptidergic organization of the cat periaqueductal gray: II. The distribution of immunoreactive substance P and vasoactive intestinal polypeptide. J Neurosci 3:1437-1449. (Pubitemid 13016170)
51. Brodin E, Rosen A, Schott E, Brodin K (1994): Effects of sequential removal of rats from a group cage, and of individual housing of rats, on substance P, cholecystokinin and somatostatin levels in the periaqueductal grey and limbic regions. Neuropeptides 26:253-260. (Pubitemid 24118786)
52. Chi CC, Flynn JP (1971): Neural pathways associated with hypothalamically elicited attach behavior in cats. Science 171:703-706.
53. Chi CC, Flynn JP (1971): Neuroanatomic projections related to biting attack elicited from hypothalamus in cats. Brain Res 35:49-66.
54. Siegel A, Roeling TA, Gregg TR, Kruk MR (1999): Neuropharmacology of brain-stimulation-evoked aggression. Neurosci Biobehav Rev 23:359-389. (Pubitemid 29053212)
55. Bergström M, Hargreaves RJ, Burns HD, Goldberg MR, Sciberras D, Reines SA, et al. (2004): Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant. Biol Psychiatry 55:1007-1012. (Pubitemid 38581916)
56. Siegel A, Bhatt S, Bhatt R, Zalcman SS (2007): The neurobiological bases for development of pharmacological treatments of aggressive disorders. Curr Neuropharmacol 5:135-147. (Pubitemid 47019427)
57. Mantyh PW, Gates T, Mantyh CR, Maggio JE (1989): Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues. J Neurosci 9:258-279. (Pubitemid 19057192)
58. Nakaya Y, Kaneko T, Shigemoto R, Nakanishi S, Mizuno N (1994): Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. J Comp Neurol 347:249-274. (Pubitemid 24273427)
59. Jacobs C, Van Den Broeck W, Simoens P (2006): Increased volume and neuronal number of the basolateral nuclear group of the amygdaloid body in aggressive dogs. Behav Brain Res 170:119-125.